Legend Capital Closes $156 Million Phase II for RMB Healthcare Fund

Legend Capital, the controlling shareholder of Lenovo Group, completed a $156 million capital raise for its RMB China healthcare fund. The fund will invest in innovative medicines, precise treatments, medical devices, diagnostic technologies, medical services and genetic technologies. This is the second phase of the RMB healthcare fund, which closed its first fundraising last year. The second phase will expand its investing strategy across early-stage to later-stage investments. The firm also plans to close a US dollar healthcare fund in Q3 of this year. More details.... Share this with colleagues: // //